Clinical Trial Update: Lenalidomide-Adriamycin-Dexamethasone (RAD) Induction Followed by Stem Cell Transplant in Newly Diagnosed Multiple Myeloma [Phase 2]

View source ↗

Summary

Phase 2 trial evaluating lenalidomide, doxorubicin (Adriamycin), and dexamethasone induction followed by stem cell transplant in newly diagnosed multiple myelom…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Multiple Myeloma

Drugs mentioned

• Adriamycin (doxorubicin)
• Decadron (Dexamethasone)
• Revlimid (lenalidomide)

Snippet

Sponsor: Wuerzburg University Hospital | Conditions: Multiple Myeloma | Phase 2 | Status: COMPLETED